CFAP61-AS1

Across TCGA pan-cancer cohorts, CFAP61-AS1 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of CFAP61-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CFAP61-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CFAP61-AS1 is over-expressed in tumor, although a few such as KICH and PAAD show the opposite, repressed pattern.

HNSC, KICH, and LIHC are the cancer types where CFAP61-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CFAP61-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+0.206	.001	12	view →
KICH	Female	II,III,IV	−0.590	<.001	9	view →
LIHC	All	All	+0.325	<.001	6	view →
STAD	Male	II,III,IV	+0.220	<.001	4	view →
BLCA	All	All	+0.534	.027	3	view →
PAAD	Male	All	−0.244	.033	2	view →
COAD	All	II,III,IV	+0.171	.008	2	view →
KIRC	Male	All	−0.146	.006	2	view →
KIRP	Female	All	−0.262	.011	1	view →
THCA	Male	All	+0.121	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

CFAP61-AS1–HNSC

Open the HNSC breakdown →